NPI: 1083045140 · JEFFERSONVILLE, IN 47130 · Durable Medical Equipment & Medical Supplies · NPI assigned 11/27/2013
Authorized official BURR, KEVIN controls 20+ related entities in our dataset. Read more
| Authorized Official | BURR, KEVIN (SECRETARY) |
| NPI Enumeration Date | 11/27/2013 |
Other providers sharing the same authorized official: BURR, KEVIN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,591 | $4.00M |
| 2019 | 4,288 | $6.47M |
| 2020 | 5,546 | $7.48M |
| 2021 | 6,852 | $9.99M |
| 2022 | 6,521 | $9.67M |
| 2023 | 6,179 | $9.70M |
| 2024 | 5,378 | $7.75M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | 16,400 | 14,513 | $20.47M |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | 4,161 | 3,296 | $5.90M |
| J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg | 2,321 | 1,584 | $5.32M |
| J2357 | Injection, omalizumab, 5 mg | 2,328 | 1,990 | $4.95M |
| Q9991 | Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg | 3,364 | 2,628 | $4.93M |
| J2315 | Injection, naltrexone, depot form, 1 mg | 3,410 | 3,055 | $4.42M |
| J2323 | Injection, natalizumab, 1 mg | 361 | 260 | $2.02M |
| J2182 | Injection, mepolizumab, 1 mg | 831 | 592 | $1.99M |
| J0517 | Injection, benralizumab, 1 mg | 386 | 340 | $1.68M |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 912 | 695 | $1.04M |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 658 | 550 | $785K |
| J0897 | Injection, denosumab, 1 mg | 582 | 510 | $745K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 141 | 115 | $411K |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 78 | 41 | $232K |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 80 | 71 | $105K |
| J3490 | Unclassified drugs | 61 | 49 | $59K |
| 90378 | 101 | 55 | $8K | |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 254 | 177 | $905.14 |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | 453 | 391 | $624.24 |
| S5000 | Prescription drug, generic | 61 | 56 | $337.94 |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | 412 | 241 | $173.34 |